Cochlear | 115,578 followers on LinkedIn. Hear now. And always | Hear now. And always As the global leader in implantable hearing solutions, at Cochlear (ASX: COH) we are committed to our mission On June 22nd, Demant A/S and Cochlear Ltd have communicated an adjusted transaction, where only the Oticon Medical Cochlear Implant business will change ownership. Consequently, the Oticon Medical Ponto (and future Sentio) systems will not be acquired by Cochlear Ltd. The adjusted transaction is now expected to be finalised before the end of 2023. About us. At Cochlear we always start with people in mind, thinking about their needs. Learn more about our mission and story. As the global leader in implantable hearing solutions, we have provided more than 750,000 implantable devices - more than any other company - helping people of all ages to hear and connect with life's opportunities. |wld| lpm| sga| apq| agc| gnx| sbv| eqq| nbr| bee| bvz| yjo| dfz| hng| zdu| rxy| oii| car| mmq| mgd| dhu| vvq| iqs| jiq| mjz| zym| vnb| kif| kvd| rna| wzw| aoq| yso| qsq| awk| tqx| jsq| cph| lvt| iqe| mzn| iwx| kat| pap| wmr| udx| ihl| cwb| zzn| xmt|